- Home
- NXL vs NDLS Comparison
NXL vs NDLS Comparison
Compare NXL & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- NDLS
- Stock Information
- Founded
- NXL 2010
- NDLS 1995
- Country
- NXL United States
- NDLS United States
- Employees
- NXL N/A
- NDLS N/A
- Industry
- NXL Medical Specialities
- NDLS Restaurants
- Sector
- NXL Health Care
- NDLS Consumer Discretionary
- Exchange
- NXL Nasdaq
- NDLS Nasdaq
- Market Cap
- NXL 31.1M
- NDLS 34.3M
- IPO Year
- NXL 2022
- NDLS 2013
- Fundamental
- Price
- NXL $1.94
- NDLS $1.13
- Analyst Decision
- NXL Strong Buy
- NDLS Strong Buy
- Analyst Count
- NXL 1
- NDLS 2
- Target Price
- NXL $5.00
- NDLS $3.00
- AVG Volume (30 Days)
- NXL 123.3K
- NDLS 122.0K
- Earning Date
- NXL 03-14-2025
- NDLS 03-06-2025
- Dividend Yield
- NXL N/A
- NDLS N/A
- EPS Growth
- NXL N/A
- NDLS N/A
- EPS
- NXL N/A
- NDLS N/A
- Revenue
- NXL $168,721.00
- NDLS $493,271,000.00
- Revenue This Year
- NXL $175.37
- NDLS $2.24
- Revenue Next Year
- NXL $334.78
- NDLS $1.18
- P/E Ratio
- NXL N/A
- NDLS N/A
- Revenue Growth
- NXL 52.35
- NDLS N/A
- 52 Week Low
- NXL $0.53
- NDLS $0.55
- 52 Week High
- NXL $4.49
- NDLS $2.36
- Technical
- Relative Strength Index (RSI)
- NXL 37.77
- NDLS 42.82
- Support Level
- NXL $2.16
- NDLS $1.03
- Resistance Level
- NXL $2.57
- NDLS $1.20
- Average True Range (ATR)
- NXL 0.22
- NDLS 0.09
- MACD
- NXL -0.00
- NDLS 0.00
- Stochastic Oscillator
- NXL 9.52
- NDLS 35.29
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.